Key messages of the recommendations for the treatment of atrial fibrillation of the European Association of Cardiology 2024 (ESC)

One of the key messages of these recommendations is optimal therapy using the AF-CARE principle, which includes: C - treatment of comorbidities and risk factors: A - prevention of stroke and thromboembolism: R - reduction of symptoms by controlling heart rate and rhythm and E - evaluation and dynamic reassessment. Optimal treatment according to the AF-CARE principle includes: lifestyle recommendations, psychosocial support, education and awareness raising for patients, family members and caregivers, seamless coordination between primary health care and specialized AF care. Shared decision-making, multidisciplinary team approach, patient education and empowerment, with an emphasis on self-care, structured educational programs for healthcare workers and technological support are also highlighted. AF is associated with a high risk of thromboembolism, including ischemic stroke, arterial embolism, and their complications. Oral anticoagulant therapy should be given to almost all patients with clinical AF, except those at low risk of thromboembolism. Locally validated scores or the CHA2DS2-VA score are recommended to assess the risk of thromboembolism and to reassess at periodic intervals in order to make adequate decisions about the use of oral anticoagulant therapy